FDA Revises Equivalence Criteria For Generic Drug Approval
In its draft guidance, the FDA spelled out general study characteristics to determine so-called bioequivalence. That refers to how fast and how much of an active ingredient shows up at the area of a person’s body where it’s intended to work.
Separate guidance is coming...
To view the full article, register now.